0622

Join us in a journey across the global south, as we take a look at a selection of open science projects run by the Drugs for Neglected Diseases initiative. From there, look to the future as we ask the experts: can AI reshape pharma forever? Also in the issue, an interview with a Kyiv-based CRO weathering Russian invasion, the story behind a Euro-African vaccine manufacturing initiative, and the strange case of Sanofi’s ASMR foray into Soundcloud…

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

I want to receive an alert when the next issue is available online

Articles featured in this issue

Business & Regulation Business Practice

Words With the Fearless Leader

06/22/2022 | Angus Stewart | 6 min read

Where did DNDi come from – and where is it going? We ask the nonprofit organization’s chief for a rundown

Discovery & Development Clinical Trials

A LEAP of Faith

06/28/2022 | Angus Stewart | 6 min read

Two friends, two countries; one disease, one network to fight it. We spoke to two leaders of DNDi’s Leishmaniasis East Africa Network.

Business & Regulation Marketing

The Pills Are Alive…

05/26/2022 | Angus Stewart | 3 min read

…with the Sounds of Sanofi. That’s right, a pharma company has opened a SoundCloud account.

Business & Regulation COVID-19

A Tale of Two Continents

04/13/2022 | Angus Stewart

African vaccine production needs a boost. Here’s how Aspen is working to make that happen.

Business & Regulation Supply Chain

The Early Bird Gets the…

04/04/2022 | Joy Aho

What are the key decisions that need to be made for cell therapy supply chains?

Business & Regulation Advanced Medicine

Champions of Cell and Gene Therapy

04/26/2022 | Angus Stewart

In our second C+G Champions installment, we ask industry leaders in the cell and gene field to answer key questions about the industry.

Discovery & Development Drug Discovery

The Final Frontier for Regenerative Medicine

04/25/2022 | Stephanie Vine

What will drug development look like aboard a new commercial space station?

Manufacture Biosimilars

Towards Better Biosimilar Access

05/25/2022 | Maryam Mahdi | 4 min read

Though in theory, biosimilars should help improve medicines access, what challenges still stand in the way of therapeutic equality and equity?

Manufacture Packaging

Clinical Trials: Getting Smart with Pill Dispensing

06/02/2022 | 6 min read

How can smart packaging designs help boost medical adherance?

Business & Regulation Trends & Forecasts

Kyiv: Escape and Return

05/10/2022

Ukrainian drug discovery has been disrupted by war. We spoke to leaders of its largest player about the domestic industry’s past, present, and future.